Physicians and academicians specialized in cancer treatments came together at the Oncology symposium organized by Egepol Hospitals for the first time this year at the Wyndham Grand Izmir Hotel.
The first session of the symposium was held under the title of 'Neodjuvant (TNT) Treatment Approach in Colorectal Cancers'. Session Chairs were Prof. Dr. İlhan Öztop, Prof. Dr. Serdar Özkök, Prof. Dr. Umut Varol; Prof. Dr. Işıl Somalı, Assoc. Prof. Dr. Emin Lapsekili, Assoc. Prof. Dr. Ümit Alakuş and Spec. Dr. Merve Kılıç provided detailed information about treatment approaches and processes in rectum and colon cancer.
The second session titled “Neoadjuvant Treatments in Breast Cancer” was chaired by Prof. Dr. Tuğba Yavuzşen, Prof. Dr. Zümre Alıcıkuş and Prof. Dr. Arzu Yaren. In the second session, Assoc. Prof. Dr. Esin Oktay, Prof. Dr. Işıl Başara, Prof. Dr. Ali Sevinç and Assoc. Prof. Dr. Zeliha Güzelöz Çapar made presentations on diagnosis and treatments in breast cancer.
In the presentations, it was stated that Colorectal (CRC) is the 3rd most common cancer type in the world, and it was emphasized that breast cancer is the most common type among women; it was emphasized that early diagnosis and treatment save lives.
NEOADJUVANT TREATMENT REDUCE TUMORS
The following information was provided about neoadjuvant therapy in the presentations: “Neoadjuvant therapy is usually the first-stage treatment method applied to reduce tumor size before the main treatment method planned as surgery. Chemotherapy, radiation therapy and hormone therapies are the main approaches that constitute neoadjuvant therapy. Neoadjuvant chemotherapy has more than one application method. Neoadjuvant chemotherapy can be administered orally (by mouth), intravenously (through a vein) and by injection. The main proven benefits of neoadjuvant chemotherapy are to enable the removal of tumors that cannot be removed with surgical operations and to enable inoperable tumors to be operated on.”
